Anpario plc (LON:ANP - Get Free Report) shares crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of GBX 351.99 ($4.39) and traded as high as GBX 380 ($4.74). Anpario shares last traded at GBX 374.65 ($4.67), with a volume of 36,363 shares.
Wall Street Analyst Weigh In
ANP has been the subject of a number of recent research reports. Shore Capital restated a "house stock" rating on shares of Anpario in a research note on Wednesday, September 11th. Canaccord Genuity Group lifted their price objective on Anpario from GBX 340 ($4.24) to GBX 370 ($4.62) and gave the company a "buy" rating in a report on Wednesday, September 18th.
Get Our Latest Stock Analysis on Anpario
Anpario Stock Up 1.1 %
The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. The firm has a 50 day simple moving average of GBX 351.99 and a 200-day simple moving average of GBX 317.96. The stock has a market capitalization of £64.08 million, a price-to-earnings ratio of 2,105.28 and a beta of 0.58.
Insider Buying and Selling
In other Anpario news, insider Karen Prior sold 14,000 shares of the business's stock in a transaction on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.74), for a total value of £53,200 ($66,367.27). 30.51% of the stock is currently owned by corporate insiders.
Anpario Company Profile
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Read More
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
